key: cord-0999520-cq1s2y4e authors: Lowe, Henry; Toyang, Ngeh; Steele, Blair; Bryant, Joseph; Ngwa, Wilfred; Nedamat, Kaveh title: The Current and Potential Application of Medicinal Cannabis Products in Dentistry date: 2021-09-10 journal: Dent J (Basel) DOI: 10.3390/dj9090106 sha: 2d220daf19deb50fd8286d9214f50cdb03bc3c5f doc_id: 999520 cord_uid: cq1s2y4e Oral and dental diseases are a major global burden, the most common non-communicable diseases (NCDs), and may even affect an individual’s general quality of life and health. The most prevalent dental and oral health conditions are tooth decay (otherwise referred to as dental caries/cavities), oral cancers, gingivitis, periodontitis, periodontal (gum) disease, Noma, oro-dental trauma, oral manifestations of HIV, sensitive teeth, cracked teeth, broken teeth, and congenital anomalies such as cleft lip and palate. Herbs have been utilized for hundreds of years in traditional Chinese, African and Indian medicine and even in some Western countries, for the treatment of oral and dental conditions including but not limited to dental caries, gingivitis and toothaches, dental pulpitis, halitosis (bad breath), mucositis, sore throat, oral wound infections, and periodontal abscesses. Herbs have also been used as plaque removers (chew sticks), antimicrobials, analgesics, anti-inflammatory agents, and antiseptics. Cannabis sativa L. in particular has been utilized in traditional Asian medicine for tooth-pain management, prevention of dental caries and reduction in gum inflammation. The distribution of cannabinoid (CB) receptors in the mouth suggest that the endocannabinoid system may be a target for the treatment of oral and dental diseases. Most recently, interest has been geared toward the use of Cannabidiol (CBD), one of several secondary metabolites produced by C. sativa L. CBD is a known anti-inflammatory, analgesic, anxiolytic, anti-microbial and anti-cancer agent, and as a result, may have therapeutic potential against conditions such burning mouth syndrome, dental anxiety, gingivitis, and possible oral cancer. Other major secondary metabolites of C. sativa L. such as terpenes and flavonoids also share anti-inflammatory, analgesic, anxiolytic and anti-microbial properties and may also have dental and oral applications. This review will investigate the potential of secondary metabolites of C. sativa L. in the treatment of dental and oral diseases. Oral and dental diseases contribute to a significant economic burden of productivity loss, particularly in low-and middle-income countries that lack the appropriate resources to treat such conditions. Regions such as Western Europe, Australasia, Central Europe, High-Income North America, and High-Income Asia Pacific were found to have the highest levels of per capita dental expenditures, with untreated dental caries (tooth decay) being the most prevalent health condition [1] . On the same tangent, oral cancers have a very high mortality rate in Jamaica [2] . Periodontitis (severe periodontal disease) 20-50% of global population [8, 9] 4. Oral Cancer (that is, cancers of the lip, oral cavity, and oropharynx) 657,000 new cases annually [6] 5. Oro-dental trauma Approximately 1 billion people have had traumatic dental injuries (TDIs) at some point in their lives. [10] Medicinal plants such as Acacia catechu (L.f.) Willd., Spilanthes spp., Wrightia tinctoria R.Br., Cannabis sativa L., Ophiopogonis radix, Salvia officinalis L., Syzygium aromaticum (L.) Merr. and L.M.Perry (clove), Allium sativum L. (garlic), and Datura stramonium L. have been utilized across traditional Asian, African and Indian medicine for several hundred, and possibly thousand years, to treat many ailments. These include oral and dental diseases such as oral ulcers, periodontal abscesses, oral mucositis, oral microbial infections, oral inflammatory diseases, toothache, pyorrhea, acute dental pulpitis, halitosis and sore throat [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . More recently, traditional Chinese medicine (TCM) has been utilized in the treatment of oral diseases including, but not limited to oral lichen planus, recurrent aphthous stomatitis, oral leukoplakia, and Sjögren's syndrome [11] . In addition to utilization in other traditional medicinal systems, medicinal plants such as Mentha piperita L. (peppermint), Melaleuca alternifolia (Maiden and Betche) Cheel (tea tree oil), Calendula officinalis L., Aloe vera L., Citrus limon (L.) Osbeck, Camomilla matriciana, Rosmarinus officinalis L. (rosemary), Thymus vulgaris L. (thyme), and Eugenol (a compound produced by multiple medicinal plants), are also widely utilized in western complementary medicine in the treatment of oral and dental diseases [23] [24] [25] [26] . Cannabis sativa L. has a long history in traditional Asian, African and Indian medical systems/pharmacopoeias, for the treatment of oral and dental diseases since at least 2700BC in China [27, 28] . As it relates to the treatment of oral and dental disease, in these traditional medical systems C. sativa L., was utilized for toothache management, though it is also likely that the plant may have also been used in the treatment and prevention of dental caries and reduction in gum inflammation [29] . C. sativa L. produces many pharmacologically active secondary metabolites including cannabinoids, terpenes and flavonoids that share anti-inflammatory, antioxidant antimicrobial, analgesic, anti-cancer, anxiolytic properties [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . This, along with the finding that cannabinoid receptors are also distributed within the oral cavity has resulted in an increased focus toward alternative, cannabinoid-based pharmaceutical compositions for the maintenance of oral health and in the treatment of oral diseases. There is also an increasing shift toward alternative natural oral hygiene products. One major reason is the increasing resistance to synthetical antimicrobials and the possible adverse effects of chemical agents [40] . To date, cannabinoid-based pharmaceutical compositions have been patented for the maintenance of general oral hygiene and for specific oral and dental diseases. Table 2 below lists examples of such patents. This review will attempt to make an argument for the therapeutic potential of secondary metabolites of C. sativa L. against oral and dental diseases, based on the aforementioned therapeutic properties of metabolites and the implication of the ECS in oral and dental diseases. However, further studies will be required to elucidate mechanisms of action, efficacies, safeties and toxicities of these secondary metabolites. There is currently a wide range of cannabinoid-based oral products currently on the market, and studies being conducted on cannabinoid-based pharmaceuticals in general, are increasingly positive and evidence-based. These products include cannabidiol (CBD) capsules, CBD pills, CBD Hemp Oil Tinctures, CBD Oil, CBD-infused toothpastes, CBD Oral Sprays, CBD-infused mouthwashes, CBD chewing gum and even CBD-infused dental fillings [40] [41] [42] [43] . The aforementioned products are primarily used as analgesics to provide relief from tooth pain and gum soreness, and as anti-microbials and anti-septic agents to maintain oral hygiene, and anti-inflammatory agents to control inflammation of the gums [44, 45] . Despite the myriad of existing cannabinoid-based oral products, the scientific literature on the safety, efficacy, toxicity and quality of these pharmaceuticals, is limited. Ultimately, the regulatory framework governing these compounds and their use thereof, as defined by the U.S. Food and Drug Administration, is also in its nascent stage of development. On this tangent, it is suggested that patients seek professional medical advice before using cannabinoid-based oral products. These regulatory frameworks are built on rigorous, scientific-and evidence-based data, which are currently lacking. In one preliminary observation, scientists found that cannabinoids were more effective in reducing bacterial colony count in dental plaques when compared to Colgate and Oral B, industry-standard, synthetic oral hygiene products [46] . Due to antimicrobial resistance, it was then concluded that these cannabinoids may be a safer alternative to traditional synthetic oral hygiene products [46] . In another study, the efficacy of two mouthwash products, one containing a <1% cannabidiol (CBD) per weight and another containing < 1% cannabigerol (CBG) per weight, respectively, were investigated against total-culturable bacteria from dental plaque samples [47] . In comparison to chlorhexidine 0.2%, frequently used in traditional synthetic mouthwash, both cannabinoid-infused mouthwash products demonstrated very similar bactericidal efficacy [47] . Table 2 . Examples of cannabinoid-based pharmaceutical compositions have been patented for the maintenance of general oral hygiene and for specific oral and dental diseases. Reference (Patent Number) Cannabis-based composition comprising cannabis-extract, derivatives, and/or at least one synthetic cannabinoid intended for the treatment of dental pulp infection, pulp inflammation, dental (jaw) bone defects [48] 2. Cannabinoid-based oral care composition (tooth paste, a tooth powder, or a mouthwash solution) for the treatment of oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain. Cannabinoid may be cannabidiol and/or cannabigerol. [49] 3. Extract of C. sativa L. (toothpaste, oral cleanser, or oral spray) for the treatment of dental caries. [50] 4. Cannabinoid-based chewing gum compositions intended for the alleviation of pain. [51] The Endocannabinoid System (ECS) is a network of proteins (receptors, their ligands and biosynthesis and degradative enzymes) widely distributed throughout mammalian tissues and cells in virtually animal species [52, 53] . The ECS is primarily responsible for maintaining internal homeostasis and directly influences physiological process regulating anxiety, feeding behavior/appetite emotional behavior, depression, nervous functions, endocrine regulation, energy balance, neurogenesis, neuroprotection, reward, cognition, learning, memory, pain, sensation, fertility, pregnancy, and pre-and post-natal development [54] [55] [56] [57] [58] [59] [60] [61] [62] . The ECS plays a role in multiple physiological and pathophysiological processes, making it a valuable target for the treatment of many diseases and disorders such as multiple types of cancers, cardiovascular diseases, neurodegenerative diseases, psychiatric disorders, mood and anxiety disorders, obesity, and substance-abuse disorders [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] . On the same tangent, it is also suggested that Squamous Cell Carcinoma of the Oral Tongue (SCCOT) may be the result of a dysregulation of endocannabinoid system signaling [76] . Phytocannabinoids, referred to as classical cannabinoids, are a class of terpenophenolic compounds that are naturally produced by C. sativa L. plant [77, 78] . Over 100 cannabinoids have been isolated from C. sativa L. to date [79] . The two major, most studied and most abundantly produced phytocannabinoids are ∆ 9 -THC (∆ 9 -Tetrahydrocannabinol) and Cannabidiol (CBD). Others include Tetrahydrocannabivarin (THCV), Cannabigerovarin (CBGV), Cannabichromene (CBC), Cannabichromevarin (CBCV), Cannabigerol (CBG), Cannabivarin (CBDV), Cannabivarin (CBV), and Cannabicyclol (CBL). The chemical structures of major secondary metabolites produced by C. sativa L. are shown in Table 3 below. Due to the potent properties of the major cannabinoids, they may have therapeutic potential against oral and dental diseases. Other major secondary metabolites produced by C. sativa L. that have a wide range of significant of therapeutic benefits are flavonoids and terpenes. Secondary metabolites are organic compounds produced by microorganisms and plants that play roles in a number of processes that give the plant or microorganism comparative advantage, may play a role in survival of the microorganism or plant, play a role in the aroma (terpenes), pigmentation and flavour of the plant (flavonoids), and that may have pharmacological/health benefits [80] [81] [82] [83] . In addition to these roles, many cannabinoid-and non-cannabinoid secondary metabolites produced by C. sativa L., are analgesic, antimicrobial, anti-cancer, anti-inflammatory, anxiolytic, anti-depressant, relaxant, and antioxidant [35, 39, [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] . Together these cannabinoids and non-cannabinoid molecules work synergistically to enhance the biological effect of C. sativa L. This is known as the "Entourage Effect" [95] [96] [97] . As such, pharmaceuticals made of these secondary metabolites may have a role in the treatment of oral and dental diseases. Table 3 lists major secondary metabolites of C. sativa L. and their properties that could make them useful in dentistry. Delta 9-tetrahydrocannabinol (Δ 9 -THC) Anti-microbial Anti-inflammatory Analgesic Antioxidant Anti-cancer Anti-tumor [84, [98] [99] [100] [101] [102] [103] [104] [105] 2. Anti-microbial Anti-inflammatory Analgesic Anti-cancer Anti-metastatic Antioxidant Analgesic Anti-nociceptive [35, 84, [98] [99] [100] [101] [102] [103] [106] [107] [108] [109] [110] 3. Anti-microbial Antibacterial and Antifungal Analgesic Anti-nociceptive Antioxidant Anti-inflammatory Anti-depressant [84, [111] [112] [113] [114] [115] [116] 4. Anti-microbial Analgesic Antioxidant [84, [117] [118] [119] 5. Anti-microbial Analgesic Antioxidant [84, 120, 121] Major Terpenes 1. Antimicrobial Antioxidant Potent analgesic Antioxidant; neuroprotective; antiinflammatory. Anti-cancer. [85, 86, [122] [123] [124] [125] Cannabidiol (CBD) Anti-microbial Anti-inflammatory Analgesic Anti-cancer Anti-metastatic Antioxidant Analgesic Anti-nociceptive [35, 84, [98] [99] [100] [101] [102] [103] [106] [107] [108] [109] [110] 3. 1. Anti-microbial Anti-inflammatory Analgesic Antioxidant Anti-cancer Anti-tumor [84, [98] [99] [100] [101] [102] [103] [104] [105] 2. Anti-microbial Anti-inflammatory Analgesic Anti-cancer Anti-metastatic Antioxidant Analgesic Anti-nociceptive [35, 84, [98] [99] [100] [101] [102] [103] [106] [107] [108] [109] [110] 3. Anti-microbial Antibacterial and Antifungal Analgesic Anti-nociceptive Antioxidant Anti-inflammatory Anti-depressant [84, [111] [112] [113] [114] [115] [116] 4. Anti-microbial Analgesic Antioxidant [84, [117] [118] [119] 5. Anti-microbial Analgesic Antioxidant [84, 120, 121] Major Terpenes 1. Antimicrobial Antioxidant Potent analgesic Antioxidant; neuroprotective; antiinflammatory. Anti-cancer. [85, 86, [122] [123] [124] [125] Cannabichromene (CBC) Anti-microbial Antibacterial and Anti-fungal Analgesic Anti-nociceptive Antioxidant Anti-inflammatory Anti-depressant [84, [111] [112] [113] [114] [115] [116] 4. Delta 9-tetrahydrocannabinol (Δ 9 -THC) Anti-microbial Anti-inflammatory Analgesic Antioxidant Anti-cancer Anti-tumor [84, [98] [99] [100] [101] [102] [103] [104] [105] 2. Anti-microbial Anti-inflammatory Analgesic Anti-cancer Anti-metastatic Antioxidant Analgesic Anti-nociceptive [35, 84, [98] [99] [100] [101] [102] [103] [106] [107] [108] [109] [110] 3. Anti-microbial Antibacterial and Antifungal Analgesic Anti-nociceptive Antioxidant Anti-inflammatory Anti-depressant [84, [111] [112] [113] [114] [115] [116] 4. Anti-microbial Analgesic Antioxidant [84, [117] [118] [119] 5. Anti-microbial Analgesic Antioxidant [84, 120, 121] Major Terpenes 1. Delta 9-tetrahydrocannabinol (Δ 9 -THC) Anti-microbial Anti-inflammatory Analgesic Antioxidant Anti-cancer Anti-tumor [84, [98] [99] [100] [101] [102] [103] [104] [105] 2. Anti-microbial Anti-inflammatory Analgesic Anti-cancer Anti-metastatic Antioxidant Analgesic Anti-nociceptive [35, 84, [98] [99] [100] [101] [102] [103] [106] [107] [108] [109] [110] 3. Anti-microbial Antibacterial and Antifungal Analgesic Anti-nociceptive Antioxidant Anti-inflammatory Anti-depressant [84, [111] [112] [113] [114] [115] [116] 4. Anti-microbial Analgesic Antioxidant [84, [117] [118] [119] 5. Anti-microbial Analgesic Antioxidant [84, 120, 121] Major Terpenes 1. 8. Antimicrobial; Anti-inflammatory; Analgesic; Nociception inhibition; Antimicrobial [35,92,122,125,1 41,142] Major Flavonoids Cannflavin A Analgesic Anti-inflammatory [33, [143] [144] [145] [146] 2. Analgesic Anti-inflammatory [33, [143] [144] [145] [146] Endogenous cannabinoids such as Anandamide (AEA/N-arachidonoylethanolamine) and Palmitylethanolamide (PEA) have also demonstrated analgesic effects [147] . Synthetic cannabinoids such as HU-120, HU-308, HU-320, WIN-55,212-2, JWH-133, JWH-015, nabilone, also demonstrate analgesic, anti-microbial, anti-inflammatory, anti-cancer, anti-angiogenic, anti-metastatic properties and may also be useful in the treatment of oral and dental diseases [148] [149] [150] [151] [152] [153] [154] [155] . Cannabinoid receptors such as the transient receptor potential vanilloid channel type 1 (TRPV1), cannabinoid receptors type 1(CB1) and cannabinoid receptors type 2 (CB2) in addition to other cannabinoid receptors located in the salivary glands may be novel therapeutic targets in the treatment of certain oral diseases [156] [157] [158] . Cannabinoid receptors located in salivary glands (particularly submandibular acinar cells) have also been implicated in the regulation of salivation and saliva content and thus may even be useful in the treatment of Xerostomia ("dry-mouth") [158, 159] . On this same tangent, AM251 and AM630, CB1 and CB2 antagonists, respectively, were shown to block the inhibitory effects of anandamide (AEA) on saliva secretion, and in doing so, increased saliva secretion [158] . 8. Antimicrobial; Anti-inflammatory; Analgesic; Nociception inhibition; Antimicrobial [35, 92, 122 Endogenous cannabinoids such as Anandamide (AEA/N-arachidonoylethanolamine) and Palmitylethanolamide (PEA) have also demonstrated analgesic effects [147] . Synthetic cannabinoids such as HU-120, HU-308, HU-320, WIN-55,212-2, JWH-133, JWH-015, nabilone, also demonstrate analgesic, anti-microbial, anti-inflammatory, anti-cancer, anti-angiogenic, anti-metastatic properties and may also be useful in the treatment of oral and dental diseases [148] [149] [150] [151] [152] [153] [154] [155] . Cannabinoid receptors such as the transient receptor potential vanilloid channel type 1 (TRPV1), cannabinoid receptors type 1(CB1) and cannabinoid receptors type 2 (CB2) in addition to other cannabinoid receptors located in the salivary glands may be novel therapeutic targets in the treatment of certain oral diseases [156] [157] [158] . Cannabinoid receptors located in salivary glands (particularly submandibular acinar cells) have also been implicated in the regulation of salivation and saliva content and thus may even be useful in the treatment of Xerostomia ("dry-mouth") [158, 159] . On this same tangent, AM251 and AM630, CB1 and CB2 antagonists, respectively, were shown to block the inhibitory effects of anandamide (AEA) on saliva secretion, and in doing so, increased saliva secretion [158] . Analgesic Anti-inflammatory [33, [143] [144] [145] [146] Endogenous cannabinoids such as Anandamide (AEA/N-arachidonoylethanolamine) and Palmitylethanolamide (PEA) have also demonstrated analgesic effects [147] . Synthetic cannabinoids such as HU-120, HU-308, HU-320, WIN-55,212-2, JWH-133, JWH-015, nabilone, also demonstrate analgesic, anti-microbial, anti-inflammatory, anti-cancer, antiangiogenic, anti-metastatic properties and may also be useful in the treatment of oral and dental diseases [148] [149] [150] [151] [152] [153] [154] [155] . Cannabinoid receptors such as the transient receptor potential vanilloid channel type 1 (TRPV 1 ), cannabinoid receptors type 1(CB 1 ) and cannabinoid receptors type 2 (CB 2 ) in addition to other cannabinoid receptors located in the salivary glands may be novel therapeutic targets in the treatment of certain oral diseases [156] [157] [158] . Cannabinoid receptors located in salivary glands (particularly submandibular acinar cells) have also been implicated in the regulation of salivation and saliva content and thus may even be useful in the treatment of Xerostomia ("dry-mouth") [158, 159] . On this same tangent, AM251 and AM630, CB1 and CB2 antagonists, respectively, were shown to block the inhibitory effects of anandamide (AEA) on saliva secretion, and in doing so, increased saliva secretion [158] . Now than ever before, there is an increasing acceptance of the use of medical cannabis in Dentistry. Dentists are increasingly exploring and inventing more innovative, natural, safer, and more efficient, but less expensive alternatives to traditional synthetic oral medications. Despite this increasing interest, more rigorous scientific studies are required on cannabinoid-based oral products. The financial potential for cannabis-based oral hygiene products is also very promising, especially with the growth in demand and innovation in the field. Toothaches are a global, public health crisis and are one of the most common, if not the most common dental disease and the most common cause of oral pain [160, 161] . Toothaches may typically be caused by an irritation, infection, or injury to the tooth, hypersensitivity of the nerves, damage to surrounding structures of the tooth, or decay of the tooth. Although studies are limited and mechanisms of action not yet elucidated, the analgesic properties of cannabinoids such as Delta 9-tetrahydrocannabinol (∆ 9 -THC), Cannabidiol (CBD) and Cannabigerol (CBG) have implicated them in the treatment of toothaches [41, 162, 163] . The analgesic properties of the cannabinoids may also make them useful in pain-management for tooth extractions and post-operative pain management. Burning Mouth Syndrome is a neuropathic pain condition of the tongue, lips, gum, palate and/or other areas of the oral cavity, which is characterized by chronic or recurrent burning sensation [164, 165] . Although the causes have not been fully elucidated, studies suggest that the condition may be due to dysregulation of the taste and sensory nerves of the peripheral or central nervous system [166] [167] [168] . Multiple studies have investigated and confirmed the safety and efficacy of cannabinoids, in some form or another, against the symptoms of Burning Mouth Syndrome [169] . Components of the ECS have been implicated in the pathogenesis of Burning Mouth Syndrome [156, 170] . A 2014 study by Borsani and colleagues identified an increase in the expression of transient receptor potential vanilloid channel type 1 (TRPV 1 ) and cannabinoid receptors type 2 (CB 2 ), but a decrease in expression of cannabinoid receptors type 1 (CB 1 ) in epithelial cells of the tongue [156, 170] . These studies suggest that the endocannabinoid system may be a potential target for the treatment of Burning Mouth Syndrome. Dental caries, more simply referred to as "cavities" or "tooth decay", is a very common condition that affects approximately 2.3 billion people worldwide, including 530 million children [6] . Dental caries is the result of several factors including plaque-and biofilmforming bacteria such as Streptococcus mutans or Lactobacillus spp., frequent intake of sugary foods that cause acid build-up, lack of adequate teeth cleaning and subsequent demineralization/erosion of the enamel. Due to antibacterial properties, cannabidiol may have therapeutic applicability in the treatment of dental caries [47] . Other major cannabinoids such as cannabichromene, cannabigerol, Delta (9)-tetrahydrocannabinol, and cannabinol also demonstrated potent antibacterial activity against a variety of clinically relevant methicillin-resistant Staphylococcus aureus (MRSA) strains and so, may also have anti-bacterial activity against bacteria implicated in oral and dental diseases [84, 94, 117, 118] . Cannabinoid-infused mouthwashes have also demonstrated inhibition of bacterial activity in dental plaque samples with the same efficacy as chlorhexidine a common disinfectant and antiseptic agent [47] . Cannabidiol-supplemented tooth polishing powder has also been reported to inhibit dental plaque bacteria [47] . Numerous sources of anecdotal evidence strongly supports the use of a few drops of CBD oil per day for its antibacterial potential against said bacteria. Dental anxiety is a legitimate fear of anticipated pain and subsequent avoidance of professional dental care [171] . It is a phenomenon that generally begins in childhood due to conditioning from fearful parents [172, 173] , and is prevalent globally. Culture and norms also influence an individual's conditioning [174] . As a result, an individual's oral health will deteriorate to a point where even their general health, sleep pattern, overall quality of life, self-esteem, social interactions with others, and professional and personal relationships may be significantly affected [174, 175] . Multiple studies even show a positive correlation between dental anxiety and the development of dental diseases [172, [176] [177] [178] . Dental anxiety is a frequent and significant issue for dentists globally and has even been shown to be a contributing factor to their own stress levels [171, 179] . Strategies that have been developed to combat/manage dental anxiety include nonpharmacological approaches such as (1) establishment of good communication and rapport between dentist and patient, (2) systemic desensitization (3) hypnosis (4) cognitive be-haviour therapy, a type of psychological therapy aimed at removing the negative thoughts associated with dental anxiety and phobia, and (5) pharmacological interventions such as intravenous sedation, inhalation sedation, local and general anaesthesia [179] [180] [181] [182] [183] [184] [185] . Most recently, the therapeutic potential of cannabidiol for the treatment of dental anxiety has also been investigated due to its anxiolytic, panicolytic and anti-compulsive properties. One report suggests that 15-30 milligrams of CBD applied sublingually before a dental appointment may be efficacious against dental anxiety and dental pain [186, 187] . Periodontal disease is an inflammatory gum disease caused by bacterial plaque buildup, and characterized by inflammation and even bleeding of the gum. It may be considered the intermediate stage in the general progression of gum disease. Periodontal diseases include gingivitis (early-stage gum disease) and periodontitis (severe, advanced-stage gum disease), both of which are characterized by irritation and inflammation of the gum. If left untreated, the disease leads to progressive alveolar bone loss and eventually, tooth loss. Furthermore, these effects are not solely localized, but manifest systemically. The endocannabinoid system may be a promising target in the treatment of periodontal disease as it has been shown to play a role in the modulation/suppression of inflammatory responses by periodontal ligament (PDL) cells [188, 189] . The endocannabinoid anandamide (AEA) appears to play a modulatory role in periodontal inflammation and a role in the immunosuppression of human periodontal ligament cells' (hPdLCs') host response to Porphyromonas gingivalis lipopolysaccharide (P. gingivalis LPS) [188, 189] . On the same tangent, in human patients with periodontitis, AEA expression is upregulated in gingival crevicular fluid after periodontal surgery [190] . AEA has also been shown to preservice the cellular integrity of hPdLCs [189] . Palmitoylethanolamide (PEA) also exacerbated the proinflammatory effects of AEA [189] . Cannabinoids such as THC and CBD, CBC, and CBG, demonstrate potent anti-inflammatory and analgesic effects that may make them very useful in the treatment of inflammation-based gum diseases [84, 105, 110, 111, 113, 115, [188] [189] [190] [191] [192] . Associated co-morbidities on the basis of epidemiological, clinical intervention and animal model-based studies include but are not limited to cardiovascular disease, diabetes, Alzheimer's disease, rheumatoid arthritis, cancer, adverse pregnancy outcomes, inflammatory bowel disease and respiratory disease [193] . Traditionally, much of the focus of the treatment of periodontal disease has been on reducing the bacterial load. However, an opportunity exists to modulate the host inflammatory response as well, making use of the anti-inflammatory properties of cannabinoids. Those suffering from severe periodontitis exhibit elevated levels of pro-inflammatory mediators and neutrophils in their blood and local periodontal treatment reduces these inflammatory markers systemically [194] . Of particular interest is the potential for the existence of synergistic ratios between cannabinoids which when combined, can produce optimal anti-bacterial, anti-inflammatory, antioxidant and analgesic effects. One example is between CBD and CBG where studies on neuroinflammation, a key factor in amyotrophic lateral sclerosis (ALS) show that, when combined, their benefits are enhanced [194] . More research needs to be conducted in the field of oral health to see if synergies exist for this application. With the recent COVID-19 pandemic, researchers have been exploring the role that cytokine storms play in the viral infection and in particular, the role of interleukin-6 (IL-6) [195] . Studies suggest that a predictor of COVID-19 pulmonary complications is elevated levels of IL-6. Periodontitis increase levels of IL-6 both locally and systemically meaning treatment and prevention of periodontal disease can lower levels of IL-6 and, therefore, improve respiratory outcomes of COVID-19 infection, reducing mortality [195] . In a casecontrol study, periodontitis was found to be associated with COVID-19 complications including death, ICU admission, and need for assisted ventilation [196] . Systemically, those COVID-19 patients with periodontitis showed significantly higher blood levels of white blood cells, D-dimer and C Reactive Protein [196] . These biomarkers are linked to worse disease outcomes. Oral mucositis is a disease characterized by inflammation and ulceration of the mucous membranes lining the gastrointestinal tract. Oral mucositis is regarded as the most common debilitating complication of cancer-related chemotherapy and radiation that kills both malignant and healthy tissues [197] . Though evidence is limited, the antioxidant properties of cannabidiol suggest that it may be used to control the oxidative stress associated with oral mucositis [198] . Cannabinoid CB 1 and CB 2 receptor are up-regulated in certain cancer types and thus, may be potential targets to exploit in the treatment of cancer and other diseases [199] . Multiple cannabinoids have demonstrated antioxidant, anti-metastatic, anti-tumorigenic, apoptotic and anti-angiogenic properties in various cancer cell lines and thus may have therapeutic benefits in treating oral cancers [104, 157, [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] . Table 4 lists particular potential applications of secondary metabolites against oral and dental diseases. Anti-bacterial Analgesic [41, 47, 48, 84, 93, 117, 118, 191, 211] 4. Abscesses (Cannabidiol and delta9-tetrahydrocannabinol) Anti-bacterial Anti-pruritic [191] 5. Prevention of biofilm attachment on teeth (Cannabidiol and delta9-tetrahydrocannabinol) Anti-bacterial [84, 191] 6. Burning Mouth Syndrome (Cannabidiol) Analgesic [191] 7. Oral and Salivary Gland Cancers (Cannabidiol) Anti-cancer Anti-metastatic [191] 8. Periodontitis (most severe form of gum disease) (Cannabidiol, HU-320, delta9-tetrahydrocannabinol, AEA) Anti-bacterial Anti-inflammatory Analgesic [84, 151, 188, 191, 212, 213] 9. Periodontal (Gum) disease (Cannabidiol, delta9-tetrahydrocannabinol, Cannabigerol and HU-320) Anti-bacterial Anti-inflammatory Analgesic [84, 93, 117, 118, 151, 211] 10. Gingivitis (Cannabidiol, delta9-tetrahydrocannabinol, Cannabigerol, and HU-320) Anti-bacterial Anti-inflammatory Analgesic [84, 93, 117, 118, 151, 211] 11. Oral Mucositis and other forms of oral cancer (Cannabidiol, delta9-tetrahydrocannabinol, JWH-133m, WIN-55,212-2, Cannabinol, Cannabicyclol) Anti-bacterial Anti-cancer Anti-metastatic Anti-inflammatory Analgesic Antioxidant [84, 154, 191, 192, 198, 214] 12. Dental Anxiety (Cannabidiol) Anxiolytic [191, 215] 13. Sleep issues resulting from dental anxiety (Cannabidiol and delta-9-tetrahydrocannabinol (THC)) Relaxant [216] 14. Indirect enamel protectant (Cannabidiol and delta-9-tetrahydrocannabinol (THC)) The anti-bacterial properties of CBD and THC could indirectly protect the enamel by prevent plaque build-up that could ultimately lead to erosion of the enamel. [84, 191] 15. Remineralization of enamel (Hemp oil) [211] 16. Improvement of tooth sensitivity (Hemp seed oil, Cannabigerol, and CBD oil) [211, [216] [217] [218] 17. Stimulation of jaw bone osteogenesis/regeneration (Cannabidiol and delta-9-tetrahydrocannabinol (THC)) Stimulates osteogenesis in bone fracture healing [219] [220] [221] [222] Anti-bacterial Anti-inflammatory Analgesic [93, 117, 118, 191, 224, 225] 20. Digestive issues associated with anesthesia and numbing agents (Cannabidiol) Anti-emetic Anti-nauseant [216] 21. Temporomandibular Joint (TMJ) Disorder (Cannabidiol) Analgesic [226] 22. Osseointegration of dental implants (HU-308-a CB2-specific agonist) Stimulation of osteoblastic bone formation and inhibition of osteoclastic bone resorption via activation of CB2 receptors in osteoblasts and osteoclast, and subsequent maintenance of bone mass. [227] 30× more analgesic than aspirin Anti-inflammatory [33, 143, 144, 228] 2. Oral cancers that are characterized by increased production of reactive oxygen species. (Flavonols (e.g., quercetin and kaempferol)) Antioxidant; [229] 3. Inflammation-based oral diseases such. Oral cancers that are characterized by increased production of reactive oxygen species. Antioxidant; anticancer; anti-inflammatory [229] 4. Inflammation-based oral diseases. Oral cancers that are characterized by increased production of reactive oxygen species. Antioxidant and anti-inflammatory [229] Terpenes Toothache and other oral disorders that cause pain (β-caryophyllene, α-terpineol, Myrcene) Analgesic [35, 85, 86, 92, 141, 142] 2. Dental Anxiety (E.g. Linalool) Anxiolytic [86] 3. Inflammation-based oral diseases such as gingivitis, periodontal disease and periodontitis. α-terpineol(Linalool, Myrcene, α-Pinene, Ocimene, βcaryophyllene, Limonene) Anti-inflammatory [85, 92] 4. Oral cancers that are characterized by increased production of reactive oxygen species. (Myrcene, Limonene, Linalool, α-terpineol, α-Humulene, Ocimene) Antioxidant Anticancer [39, [86] [87] [88] [89] [90] [91] 5. Oral diseases such as gingivitis, periodontal disease, periodontitis and salivary gland infections that are characterized by bacterial-plaque build-up and bacterial infections. (Ocimene, α-terpineol, Linalool, α-Pinene, Limonene) Anti-microbial (anti-bacterial) [ Despite the vast anecdotal evidence of the use of cannabis and cannabinoids to treat oral and dental disorders, there is limited rigorous scientific evidence for the use of cannabinoids in dentistry. It should be noted, however, that there is generally strong evidence to support the wide therapeutic window and properties of cannabinoids, including, but not limited to their analgesic, antioxidant, anti-inflammatory, anti-microbial, anti-pruritic and anti-cancer properties. For these reasons, cannabinoids may have significant applicability in dentistry for the treatment of (1) toothaches, (2) bacterial infections causing periodontitis, gingivitis, periodontal disease, dental caries, salivary gland infections and abscesses, (3) inflammation-based oral diseases (4) oral and salivary gland cancers (5) Burning Mouth Syndrome, (6) dental anxiety, and (7) for general maintenance of oral hygiene. In addition to their wide therapeutic window, cannabinoids may also be a safer alternative to conventional, synthetic drugs used to treat oral and dental diseases, and commercial oral and dental products, in general. In order for cannabinoids and cannabinoid-based products to become mainstay in conventional dentistry, further rigorous scientific studies are required to confirm their safety, tolerability, toxicity, efficacy, optimal dosages and optimal delivery systems in the treatment of oral and dental diseases. It is only until then that we will begin to see the regulatory framework governing these compounds and their use thereof, as defined by the U.S. Food and Drug Administration, become more accepting. This includes further studies into elucidating the specific mechanisms of action of secondary metabolites of C. sativa L. in various oral and dental diseases, and in the case of dental caries, elucidating the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and the half maximal inhibitory concentration (IC 50 ) values of each cannabinoid-based pharmaceutical against causative agents of dental caries. Patients should seek professional medical advice before using cannabinoid-based oral products. Global-, Regional-, and Country-Level Economic Impacts of Dental Diseases in 2015 Jamaica's Oral Cancer Mortality Rate Is Nearly 100%. Jamaica Observer Global Economic Impact of Dental Diseases Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study Economic burden of periodontal disease in Europe and the United states of America-An updated forecast World Health Organization Global burden of severe periodontitis in 1990-2010: A systematic review and meta-regression Global Prevalence of Periodontal Disease and Lack of Its Surveillance Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study World traumatic dental injury prevalence and incidence, a meta-analysis-One billion living people have had traumatic dental injuries Traditional Chinese medicine and oral diseases: Today and tomorrow A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evid.-Based Complement A review of the role of African traditional medicine in the management of oral diseases Herbal medicines for wound healing among tribal people in Southern India: Ethnobotanical and Scientific evidences Herbal folk medicines in Northern India The impact of natural products upon modern drug discovery The Use of Medicinal Plants for the Treatment of Toothache in Ethiopia. Evid.-Based Complement Syzygium aromaticum L. (Myrtaceae): Traditional Uses Ethnobotanical investigation of traditional medicinal plants in Dugda District Ethnobotany of medicinal plants in Ada'a District, East Shewa Zone of Oromia Regional State Ethnobotanical study of medicinal plants in Ganta Afeshum District Comparative evaluation of the antimicrobial efficacy of aloe vera tooth gel and two popular commercial toothpastes: An in vitro study Effect of thymus vulgaris extract on streptococci and mutans streptococci, in comparison to chlorhexidine gluconate (in vivo study) The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats Emerging trends of herbal care in dentistry The analgesic potential of cannabinoids Marijuana in medicine: Past, present and future History of cannabis as a medicine: A review Isolation and characterization of new Cannabis constituents from a high potency variety Non-cannabinoid constituents from a high potency Cannabis sativa variety Biologically active cannabinoids from high-potency Cannabis sativa Isolation from Cannabis sativa L. of cannflavin-A novel inhibitor of prostaglandin production Chemical constituents of marijuana: The complex mixture of natural cannabinoids Non-Phytocannabinoid constituents of cannabis and Herbal Synergy PKS activities and biosynthesis of cannabinoids and flavonoids in Cannabis sativa L. plants Terpene synthases from Cannabis sativa Biosynthesis of cannflavins A and B from Cannabis sativa L Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis Novel anti-microbial therapies for dental plaque-related diseases How Effective Is CBD for Dental Pain? Sounds Like a Good Idea but Lacks Conclusive Studies Proving It Is New Cannabis Toothpaste Has People Losing Their Minds 5 Benefits of UTILIZING CBD Oral Care Cannabis for Your Mouth: R&d, Patents, and Your Next Visit to the Dentist Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of totalculturable bacterial content in dental plaque samples Cannabis and Derivatives Thereof for the Treatment of Pain and Inflammation Related with Dental Pulp and Bone Regeneration Related to Dental Jaw Bone Defects Oral Care Composition Comprising Cannabinoids Composition for Prevention or Treatment of Dental Caries Comprising Extract of Cannabis sativa Chewing Gum Compositions Comprising Cannabinoids The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation The Endocannabinoid System of Animals The emerging role of the endocannabinoid system in endocrine regulation and energy balance Roles of the endocannabinoid system in learning and memory The role of the endocannabinoid system in the neuroendocrine regulation of energy balance The role of the endocannabinoid system in pain The endocannabinoid system and pain The endocannabinoid system: Role in energy regulation. Pediatr The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility The role of the endocannabinoid system in female reproductive tissues The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy The emerging role of the endocannabinoid system in cardiovascular disease Role of the endocannabinoid system in drug addiction The endocannabinoid system and psychiatric disorders Role of the endocannabinoid system in depression and suicide Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia Role of the endocannabinoid system in Alzheimer's disease: New perspectives The endocannabinoid system: Its roles in energy balance and potential as a target for obesity treatment A possible role for the endocannabinoid system in the neurobiology of depression Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System Role of the endocannabinoid system in neurological disorders Role of the endocannabinoid system in diabetes and diabetic complications The endocannabinoid signaling system in cancer New approaches and challenges to targeting the endocannabinoid system Altered mRNA Expression of Genes Involved in Endocannabinoid Signaling in Squamous Cell Carcinoma of the Oral Tongue. Cancer Investig Cannabis sativa: The Plant of the Thousand and One Molecules Phytochemistry of Cannabis sativa L The natural functions of secondary metabolites What Are FLAVONOIDS? What Are Cannabis Flavonoids and What Do They Do? What Are Cannabis Terpenes and What Do They Do? Antibacterial cannabinoids from Cannabis sativa: A structure-activity study Effect of myrcene on nociception in mice What Are Terpenes? Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species Biological activities and composition of ferulago carduchorum essential Oil Chemical composition and anti-inflammation activity of essential oils from Citrus unshiu flower Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species Comparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds Cannabinoids-Promising Antimicrobial Drugs orIntoxicants with Benefits? Antibiotics 2020 Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain Cannabis Phytomolecule 'Entourage': From Domestication to Medical Use Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer Anticancer mechanisms of cannabinoids The use of cannabinoids as anticancer agents Cannabinoids: Potential anticancer agents Towards the use of cannabinoids as antitumour agents Cannabinoids as Anticancer Drugs Cannabinoids as novel anti-inflammatory drugs Prospects for cannabinoids as anti-inflammatory agents Antioxidative and Anti-Inflammatory Properties of Cannabidiol The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain The antimicrobial potential of cannabidiol Cannabidiol-Recent advances Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol Biological activity of cannabichromene, its homologs and isomers Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by ∆(9)-tetrahydrocannabinol Anti-inflammatory properties of cannabichromene Cannabichromene to Its Growing Portfolio of High-Quality, Pure and SUSTAINABLE Cannabinoids The Pharmacological Case for Cannabigerol Uncovering the Hidden Antibiotic Potential of Cannabis Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1 A systematic review of minor phytocannabinoids with promising neuroprotective potential Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus Therapeutic Potential of α-and β-Pinene: A Miracle Gift of Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp) The Anti-Inflammatory Properties of Terpenoids from Cannabis Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice Regulation of interleukin-8 secretion in human intestinal epithelial Caco-2 cells by alpha-humulene Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel Antibacterial, allelopathic and antioxidant activities of essential oil of Salvia officinalis L. growing wild in the Atlas Mountains of Morocco The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna Use of β-caryophyllene to combat bacterial dental plaque formation in dogs Terpenes/Terpenoids in Cannabis: Are They Important? Med. Cannabis Cannabinoids Enhancing the antimicrobial activity of d-limonene nanoemulsion with the inclusion of ε-polylysine Antimicrobial Susceptibility and Antibacterial Mechanism of Limonene against Listeria monocytogenes Mechanism of bacterial inactivation by (+)-limonene and its potential use in food preservation combined processes Anxiolytic-like activity and GC-MS analysis of (R)-(+)-limonene fragrance Analgesic-like activity of essential oils constituents Antioxidant activity of limonene on normal murine lymphocytes: Relation to H 2 O 2 modulation and cell proliferation Characterization of α-Terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells α-Terpineol reduces nociceptive behavior in mice These Marijuana-Based Painkillers Are 30 Times More Powerful Cannabis CannaFlavins 30x Stronger Than Aspirin in Cell Experiment Cannflavin A and B, prenylated flavones from Cannabis sativa L Cannflavins-From plant to patient: A scoping review Control of pain initiation by endogenous cannabinoids Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat Cannabinoids as therapeutic agents in cancer: Current status and future implications A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines 212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner Epithelial expression of vanilloid and cannabinoid receptors: A potential role in burning mouth syndrome pathogenesis Localization of Cannabinoid Receptor 1 (CB1) in Submandibular and Sublingual Salivary Glands of Mice throughout Postnatal Development Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors Cannabinoid receptors in submandibular acinar cells: Functional coupling between saliva fluid and electrolytes secretion and Ca 2+ signalling Prevalence of toothache and associated factors: A population-based study in Southeast Iran Toothache pain: A comparison of visits to physicians, emergency departments and dentists Cannabinoids and Pain: New Insights From Old Molecules Can CBD Help Relieve Toothache? Burning mouth syndrome: A review and update Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids Study: Cannabis Extracts Mitigate Symptoms of Burning Mouth Syndrome. NORML Cannabis Oil May Help Burning Mouth Syndrome Evaluating the Suitability and Potential Efficiency of Cannabis sativa Oil for Patients with Primary Burning Mouth Syndrome: A Prospective, Open-Label, Single-Arm Pilot Study The Role of Vanilloid and Cannabinoid Receptors in Taste and Pain Perception in Burning Mouth Syndrome Strategies for combating dental anxiety Dental fear and avoidance: Causes, symptoms, and consequences A clinical study of child dental anxiety Dental Anxiety and Its Consequences to Oral Health Care Attendance and Delivery The impact of dental anxiety on daily living Prevalence of dentistry phobia and its relation to missing teeth, alveolar bone loss and dental care habits in an urban community sample Clinical correlates of dental anxiety among older adults. Community Dent A radiographic study of dental health in adult patients with dental anxiety. Community Dent Strategies to manage patients with dental anxiety and dental phobia: Literature review Dental anxiety: Detection and management Psychological treatment of dental anxiety among adults: A systematic review The role of hypnotherapy in dentistry Hypnosis in dentistry The use of hypnosis in dentistry: A review Management of fear and anxiety in the dental clinic: A review A Natural Remedy for Dental Anxiety Treating Dental Anxiety with Natural Remedies Like CBD Endocannabinoids and inflammatory response in periodontal ligament cells Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia Involvement of the endocannabinoid system in periodontal healing Ten Ham, M. Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol Cannabinoids in cancer treatment: Therapeutic potential and legislation Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol Nexus between COVID-19 and periodontal disease Association between periodontitis and severity of COVID-19 infection: A case-control study Cannabidiol: An alternative therapeutic agent for oral mucositis? Emerging strategies for exploiting cannabinoid receptor agonists as medicines Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy Critical appraisal of the potential use of cannabinoids in cancer management The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids The Pros and Cons of Using Medical Marijuana to Treat Oral Cancer CBD in Dentistry-Can Cannabis Cure Cavities? Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat Maruyama, I. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition Cannabinoids and Cancer-The Evidence So Far Why Use CBD Oil Before Visiting the Dentist. Medical Daily CBD Oil Benefits for Better Dental & Overall Health CBD for Dental Pain, Anxiety, and Problems: Does It Work? The Healthy What Are the Benefits of Hemp Seed Oil in Toothpaste? Humming Hemp The Best Data Published for Medical Marijuana in Fifty Years. BioTrack: The Leading Seed-to-Sale Cannabis Software Helps Bones to Heal Cannabinoids and the skeleton: From marijuana to reversal of bone loss Cannabis and Derivatives Thereof for the Treatment of Pain and Inflammation Related with Dental Pulp and Bone Regeneration Related to Dental Jaw Bone Defects Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats Ways CBD Takes Care of Your Salivary Gland Infection Benefits of CBG for Salivary Gland Infection: Salivary Gland Inflammation CBD for Temporomandibular Joint Disorder (TMJ) Activation of CB2 cannabinoid receptors: A novel therapeutic strategy to accelerate osseointegration of dental implants Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase What Are Flavonoids? Comprehensive Guide The authors declare no conflict of interest.Sample Availability: Samples of the compounds are not available from the authors.